SlideShare a Scribd company logo
A Computational Approach to Explore
Crimean Congo Hemorrhagic Fever
PRESENTED BY:
ALICHY SOWMYA
REG. NO. 18PIM2855
M.S.(PHARM.) 1ST
SEM.
DEPARTMENT OF PHARMACOINFORMATICS
NIPER, S.A.S NAGAR
Flow of contents:
1
• Crimean Congo Hemorrhagic Fever is a disease caused by an Arbovirus, CCHFV with
a mortality rate of 6% to 50%
• The first description of hemorrhagic fever similar to that of CCHF was done in 12th
century
• Officially it was first described, in 1940s in the Crimean peninsula, and later in 1956 in
Congo
• It is geographically widespread, ranging from the Middle East and Asia to South Africa
and Eastern Europe
• CCHFV is biosafety level-4 virus making it difficult to study
Introduction:
2
Mendoza, E., et al.,, Zoonoses Public Health. 2018, 65, 465-480.
Epidemiology:
• The disease is endemic in many countries in Africa, Europe and Asia, and outbreaks
have been recorded in Kosovo, Albania, Islamic Republic of Iran, Pakistan, India, and
South Africa among other countries
• In between 2002 – 2008 , 2508 cases of CCHF with 133 deaths have been reported in
Turkey alone
• In September, 2010 an outbreak was reported in Pakistan with a case-fatality rate above
10%
• In SEAR, the first laboratory confirmed case was reported on 19 January, 2011 in
Gujarat state of India
3
http://www.searo.who.int/entity/emerging_diseases/links/CCHF_Fact_Sheet_SEARO.pdf (21 nov 10:30am).
Scenario in India:
• In India first case of CCHF was reported in Jan 2011, in Gujarat, then there was a
nosocomial outbreak talking 3 lives
• Again in 2013, there was a outbreak in Karyana village, Amreli district, Gujarat State
• CCHF-positive and fatal human cases were reported from Patan, Rajkot, Surendranagar,
and Ahmadabad districts in Gujarat State
• In may 2018, CCHF was reported in Sirohi district, Rajasthan state
Mishra et al., Lancet. 2011, 378, 372.
4
Causative agent:
• CCHFV is a second most widely distributed arbovirus after dengue virus
• Classification:
• Virion structure and molecular biology:
Flick, R.et al., Curr. Mol. Med. 2005, 5, 753-760. Contd…
5
• Transmission of virus:
Small
Mammals
and birds
Nymph
Larva
Drop off
and Molt
Oviposition
and Hatching
Adult
Humans
(Nosocomial transmissions)
Contd…
6
Aslam, S., et al.,, Biomed Rep. 2016, 4, 15-20.
Pathophysiology:
CCHFV
Tick bite
Entry from epithelium
Basolateral compartment
Release in the endothelial cells
Basolateral compartment
Spread into the blood stream
Dissemination into liver and
other tissues
Release of cytokines
Upregulation of the adhesion
molecules Damage of the immune system
Necrosis with little or no
inflammation
Activation of Endothelial cells and damage of the endothelium Uncontrolled viral
replication
Initiation of the inflammatory reactions
Intrinsic coagulation
cascade activated
Vascular permeability and
vasodilation are increased
Disseminated intravascular
coagulation
Hypotension, multiple organ
failure and shockHemorrhages
Liver dysfunction
Hemophagocytosis
CCHFV
Infected dendritic cells
and Macrophages
Spread to local lymph
nodes and spleen
7
Arasli, M., Curr Trop Med Rep. 2016, 3, 14-19.
Clinical Features:
• The CCHFV infection can be characterised by four characteristic stages viz.,
incubation, prehemorrhagic, hemorrhagic, and convalescence
Melena Epistaxis
Ecchymosis Petechiae
Ergönül, Ö.et al., Emerg. Infect. Dis. 2018, 24, 1642.
8
Treatment:
• CCHF is a severe disease in humans, with a high mortality rate, but unfortunately there
is no specific treatment available till date
• General supportive therapy is the mainstay of patient management in CCHF. Intensive
monitoring to guide volume and blood component replacement is required
• The antiviral drug ribavirin has been used in treatment of established CCHF infection
with apparent benefit, but effectiveness is yet to be proven
9
http://www.searo.who.int/entity/emerging_diseases/links/CCHF_Fact_Sheet_SEARO.pdf (21 nov 10:30am).
Prevention and control:
• As it is a tick borne virus acaricides (chemicals intended to kill ticks) can be an option
• Persons living in endemic areas should use personal protective measures
• Patients with suspected or confirmed CCHF should be isolated and cared for using
barrier nursing techniques. Proper measures are to be taken to prevent nosocomial
transmission
• Healthcare workers are at risk of acquiring infection and therefore they should take
proper precautions
• Community education initiatives should be instituted in the event of an observed
outbreak
10
http://www.searo.who.int/entity/emerging_diseases/links/CCHF_Fact_Sheet_SEARO.pdf (21 nov 10:30am).
Literature review:
11
• Javadmanesh Ali et al., have conducted in silico evaluation of the antiviral effects of the
lactoferrin against the envelopment protein (Gn and Gc) of the CCHFV
• Sitansu Kumar Verma et al., have conducting docking studies to explore the binding
sites for the antiviral compounds in RdRp of CCHFV
• Fatih Kocabas et al., used computational approaches for identification of inhibition site
in OTU Domain of CCHFV
Case study:
Contd…
12
• Materials and methods:
 Preparation of the target structure for docking
 Preparation of the docked entity
 Predicting CCHFV N binding site
 High – throughput docking studies
 Classical Molecular dynamic simulation
 Ensemble – based docking simulations
 Virtual screening procedure
• Results:
 CCHFV N druggable pocket
 Finding putative inhibitors
 Molecular dynamic studies
Contd…
Contd…
13
Contd…
Contd…
Preparation of the target structure for docking:
•The X Ray crystallographic structure of CCHFV nucleoprotein was deposited in the PDB
along with sulfate ion as a ligand with ID 4AQG with a resolution of 2.8 Å
•They have downloaded the structure and upon studying they have found that the amino
acid sequence was missing of 12 amino acid sequences which were later added using
SWISS - MODEL
•The sequences from Leu181 to Ser194 were added
14
Contd…
Contd…
Preparation of the docked entity:
15
Contd…
Contd…
Predicting CCHFV N binding site:
•In this study for determining the binding pocket, they have used DoGsiteScorer server
•Then they have used Poisson Boltzmann solver (APBS) method of PyMol software to
determine the positive charges
High – throughput docking studies:
•After the binding pockets have been recognized they have predicted the binding poses and
affinities of the compounds over the predicted binding site of CCHFV Nucleoprotein
•For this determination AutoDock Vina 1.1.2 with 40 – 34 – 40 search space was used
16
Classical Molecular dynamic simulation:
•Initially, they have used PRODRG server to generate the topology files of the ligand
•The corrections regarding their protonation states was made using the PROPKA server and
finally GROMAC was used
•The molecular dynamics simulation was done for 10 ns
Ensemble – based docking simulations:
•In this study, the ensemble was made using molecular dynamic simulation
•The simulation was performed for 10 nanoseconds (ns) and for every 2.5 ns a snapshot was
taken
Contd…
Contd…
17
Virtual screening procedure:
Contd…
Contd…
18
Contd…
Contd…
Results:
CCHFV N druggable pocket:
•Using DoGsiteScorer server they have recognised three pockets which are allegedly be the
potential binding pocket. The three pockets were as follows:
• Pocket1 (between head and tail domains)
• Pocket 2 (in the head domain)
• Pocket 3 (in the head domain)
•It was found that pocket 1 and pocket 3 consists of both positive and negative charges, and
the pocket 2 contains more positive charge
19
Contd…
Contd…Sharifi. A et al., Comput. Biol. Chem. 2017, 70, 1-6.
Three predicted pockets over CCHFV N protein are coloured by yellow, cyan and magenta
20
Contd…
Contd…
Finding putative inhibitors:
•1584 FDA approved drugs were docked with the cut-off value of -8 kcal/mol and 25 hits
were retained
•After the screening procedure only Doxycycline and Minocycline have been selected
•The docking conformation of doxycycline shows two hydrogen bonds with Leu387 and
one with Lys411 besides hydrophobic interactions with Ala302, Ile373, and Ile448
•Minocycline predicted pose comprises only one hydrogen bond with Ser386 in addition to
hydrophobic contact with Ala302, Thr381, and Ile448 residues
•It was hypothesized that doxycycline inhibits the protein more desirable than minocycline,
as it is in accordance with their obtained binding energies
21
Contd…
Contd…
A. Binding orientation of doxycycline B. Binding orientation of minocycline C. Alignment of both drugs
22
Sharifi. A et al., Comput. Biol. Chem. 2017, 70, 1-6.
Contd…
Molecular dynamic studies:
•The Root Mean Square Deviation (RMSD) of the protein backbone reveals that the
suggested ligand – protein complex reach stability at same time
(A) MD graphs of doxycycline and minocycline
(B) The RMSD plot of protein ligand complex
23
Sharifi. A et al., Comput. Biol. Chem. 2017, 70, 1-6.
Conclusion:
• CCHFV is one of the most dangerous classes of the virus and it was suggested CCHFV
Nucleoprotein could be a potential pharmaceutical target for inhibiting CCHFV
• FDA approved drugs were docked 25 dugs were filtered, virtual screening of these 25
drugs were conducted and two drugs, namely Doxycycline and Minocycline were
selected
• Molecular dynamic simulation of CCHFV N protein was done for 10ns with a snapshot
taken for every 2.5ns i.e., 4 snapshots or 4 conformations of the protein were identified
and the two drugs Doxycycline and Minocycline were docked over those 4 conformers
• It was found that both bind to all conformers with equal affinity and RMSD revealed that
the protein-ligand complex is more stable than that of protein without ligand
24
Thank youThank you

More Related Content

What's hot

H1 N1
H1 N1H1 N1
Monkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. AfuyeMonkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. Afuye
Olubunmi Afuye
 
Zoonotic Diseases By Imran
Zoonotic Diseases By ImranZoonotic Diseases By Imran
Zoonotic Diseases By Imran
guest53d8d68
 
Infection Control Guidelines in Tuberculosis [compatibility mode]
Infection Control Guidelines in Tuberculosis [compatibility mode]Infection Control Guidelines in Tuberculosis [compatibility mode]
Infection Control Guidelines in Tuberculosis [compatibility mode]
drnahla
 
Zika virus disease
Zika virus diseaseZika virus disease
Zika virus disease
Dr. Dharmendra Gahwai
 
Crimean congo hemorrhagic fever(cchf)
Crimean  congo hemorrhagic fever(cchf)Crimean  congo hemorrhagic fever(cchf)
Crimean congo hemorrhagic fever(cchf)
Hamid Abusaeedi
 
Crimean Congo Hemorrhagic Fever (CCHF) by Wazhma Hakimi
Crimean Congo Hemorrhagic Fever (CCHF) by Wazhma HakimiCrimean Congo Hemorrhagic Fever (CCHF) by Wazhma Hakimi
Crimean Congo Hemorrhagic Fever (CCHF) by Wazhma Hakimi
Dr. Wazhma Hakimi
 
Dengue fever presentation
Dengue fever presentationDengue fever presentation
Dengue fever presentation
3_minutes
 
20180929 emerging & reemerging infections
20180929 emerging & reemerging infections20180929 emerging & reemerging infections
20180929 emerging & reemerging infections
Sushrit Neelopant
 
Dengue fever presentation
Dengue fever presentationDengue fever presentation
Dengue fever presentation
fareedresidency
 
Zika virus disease
Zika virus diseaseZika virus disease
Zika virus disease
neeti purwar
 
Swine flu
Swine fluSwine flu
Swine flu
Sunil Boreddy Rx
 
Chickungunya - dr
Chickungunya  - drChickungunya  - dr
Chickungunya - dr
Dr.G.C.Sahu
 
Influenza virus a (h1 n1)
Influenza virus a (h1 n1)Influenza virus a (h1 n1)
Influenza virus a (h1 n1)
Madah Khan
 
scrub typhus
scrub typhusscrub typhus
scrub typhus
pankaj rana
 
Monkey Pox Virus
Monkey Pox VirusMonkey Pox Virus
Monkey Pox Virus
Dr Venkatesh Karthikeyan
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitis
amitakashyap1
 
Meningococcal infections
Meningococcal infectionsMeningococcal infections
Meningococcal infections
Tejasvi Charan
 
Dengue Fever
Dengue FeverDengue Fever
Dengue Fever
Asra Hameed
 
Influenza general intro. (symptoms and prevention )
Influenza general intro.  (symptoms and prevention )  Influenza general intro.  (symptoms and prevention )
Influenza general intro. (symptoms and prevention )
Reema Choudhary
 

What's hot (20)

H1 N1
H1 N1H1 N1
H1 N1
 
Monkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. AfuyeMonkeypox by Dr O.O. Afuye
Monkeypox by Dr O.O. Afuye
 
Zoonotic Diseases By Imran
Zoonotic Diseases By ImranZoonotic Diseases By Imran
Zoonotic Diseases By Imran
 
Infection Control Guidelines in Tuberculosis [compatibility mode]
Infection Control Guidelines in Tuberculosis [compatibility mode]Infection Control Guidelines in Tuberculosis [compatibility mode]
Infection Control Guidelines in Tuberculosis [compatibility mode]
 
Zika virus disease
Zika virus diseaseZika virus disease
Zika virus disease
 
Crimean congo hemorrhagic fever(cchf)
Crimean  congo hemorrhagic fever(cchf)Crimean  congo hemorrhagic fever(cchf)
Crimean congo hemorrhagic fever(cchf)
 
Crimean Congo Hemorrhagic Fever (CCHF) by Wazhma Hakimi
Crimean Congo Hemorrhagic Fever (CCHF) by Wazhma HakimiCrimean Congo Hemorrhagic Fever (CCHF) by Wazhma Hakimi
Crimean Congo Hemorrhagic Fever (CCHF) by Wazhma Hakimi
 
Dengue fever presentation
Dengue fever presentationDengue fever presentation
Dengue fever presentation
 
20180929 emerging & reemerging infections
20180929 emerging & reemerging infections20180929 emerging & reemerging infections
20180929 emerging & reemerging infections
 
Dengue fever presentation
Dengue fever presentationDengue fever presentation
Dengue fever presentation
 
Zika virus disease
Zika virus diseaseZika virus disease
Zika virus disease
 
Swine flu
Swine fluSwine flu
Swine flu
 
Chickungunya - dr
Chickungunya  - drChickungunya  - dr
Chickungunya - dr
 
Influenza virus a (h1 n1)
Influenza virus a (h1 n1)Influenza virus a (h1 n1)
Influenza virus a (h1 n1)
 
scrub typhus
scrub typhusscrub typhus
scrub typhus
 
Monkey Pox Virus
Monkey Pox VirusMonkey Pox Virus
Monkey Pox Virus
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitis
 
Meningococcal infections
Meningococcal infectionsMeningococcal infections
Meningococcal infections
 
Dengue Fever
Dengue FeverDengue Fever
Dengue Fever
 
Influenza general intro. (symptoms and prevention )
Influenza general intro.  (symptoms and prevention )  Influenza general intro.  (symptoms and prevention )
Influenza general intro. (symptoms and prevention )
 

Similar to Crimean Congo Hemorrhagic fever

CRC.pptx
CRC.pptxCRC.pptx
CRC.pptx
MaryumRasheed1
 
Diagnostics and classifications of Corona Viruses
Diagnostics and classifications of Corona VirusesDiagnostics and classifications of Corona Viruses
Diagnostics and classifications of Corona Viruses
Shinjan Patra
 
Ppt diagnostics & classification of corona viruses
Ppt diagnostics & classification of corona virusesPpt diagnostics & classification of corona viruses
Ppt diagnostics & classification of corona viruses
Shinjan Patra
 
Medi 95-e4174
Medi 95-e4174Medi 95-e4174
Medi 95-e4174
Medi 95-e4174Medi 95-e4174
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
Abdullatif Al-Rashed
 
Future of sepsis
Future of sepsisFuture of sepsis
Future of sepsis
dr nirmal jaiswal
 
Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...
Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...
Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...
Ivan Brukner
 
Oncology Discoveries, University of Chicago
Oncology Discoveries, University of ChicagoOncology Discoveries, University of Chicago
Oncology Discoveries, University of Chicago
uchicagotech
 
Sars cov 2 covid 19
Sars cov 2 covid 19Sars cov 2 covid 19
Sars cov 2 covid 19
Sravan Kumar
 
Covid -19
Covid -19Covid -19
Covid -19
Yogesh Patel
 
ANAS UMAR PRESENTATION.pptx
ANAS UMAR PRESENTATION.pptxANAS UMAR PRESENTATION.pptx
ANAS UMAR PRESENTATION.pptx
AnasUmar10
 
Cytomegalovirus infection in kidny transplantation
Cytomegalovirus infection in kidny transplantationCytomegalovirus infection in kidny transplantation
Cytomegalovirus infection in kidny transplantation
hadi lashini
 
Selene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITEDSelene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene Hess
 
Basic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshneyBasic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshney
VanshikaVarshney5
 
Kelley VanBuskirk
Kelley VanBuskirkKelley VanBuskirk
Kelley VanBuskirk
UWGlobalHealth
 
HIV IN BLOOD TRANSFUSION
HIV IN BLOOD TRANSFUSIONHIV IN BLOOD TRANSFUSION
HIV IN BLOOD TRANSFUSION
SUJAY BHOWMIK
 
1 s2.0-s2213398421000786-main
1 s2.0-s2213398421000786-main1 s2.0-s2213398421000786-main
1 s2.0-s2213398421000786-main
▄ █
 
Molecular Diagnostics.pptx
Molecular Diagnostics.pptxMolecular Diagnostics.pptx
Molecular Diagnostics.pptx
Alisha Shaikh
 
RETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONING
RETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONINGRETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONING
RETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONING
SrishtiRoy10
 

Similar to Crimean Congo Hemorrhagic fever (20)

CRC.pptx
CRC.pptxCRC.pptx
CRC.pptx
 
Diagnostics and classifications of Corona Viruses
Diagnostics and classifications of Corona VirusesDiagnostics and classifications of Corona Viruses
Diagnostics and classifications of Corona Viruses
 
Ppt diagnostics & classification of corona viruses
Ppt diagnostics & classification of corona virusesPpt diagnostics & classification of corona viruses
Ppt diagnostics & classification of corona viruses
 
Medi 95-e4174
Medi 95-e4174Medi 95-e4174
Medi 95-e4174
 
Medi 95-e4174
Medi 95-e4174Medi 95-e4174
Medi 95-e4174
 
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
 
Future of sepsis
Future of sepsisFuture of sepsis
Future of sepsis
 
Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...
Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...
Assay-for-estimating-total-bacterial-load-relative-qPCR-normalisation-of-bact...
 
Oncology Discoveries, University of Chicago
Oncology Discoveries, University of ChicagoOncology Discoveries, University of Chicago
Oncology Discoveries, University of Chicago
 
Sars cov 2 covid 19
Sars cov 2 covid 19Sars cov 2 covid 19
Sars cov 2 covid 19
 
Covid -19
Covid -19Covid -19
Covid -19
 
ANAS UMAR PRESENTATION.pptx
ANAS UMAR PRESENTATION.pptxANAS UMAR PRESENTATION.pptx
ANAS UMAR PRESENTATION.pptx
 
Cytomegalovirus infection in kidny transplantation
Cytomegalovirus infection in kidny transplantationCytomegalovirus infection in kidny transplantation
Cytomegalovirus infection in kidny transplantation
 
Selene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITEDSelene_Hess_Deciphering Antibiotic Resistance_EDITED
Selene_Hess_Deciphering Antibiotic Resistance_EDITED
 
Basic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshneyBasic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshney
 
Kelley VanBuskirk
Kelley VanBuskirkKelley VanBuskirk
Kelley VanBuskirk
 
HIV IN BLOOD TRANSFUSION
HIV IN BLOOD TRANSFUSIONHIV IN BLOOD TRANSFUSION
HIV IN BLOOD TRANSFUSION
 
1 s2.0-s2213398421000786-main
1 s2.0-s2213398421000786-main1 s2.0-s2213398421000786-main
1 s2.0-s2213398421000786-main
 
Molecular Diagnostics.pptx
Molecular Diagnostics.pptxMolecular Diagnostics.pptx
Molecular Diagnostics.pptx
 
RETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONING
RETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONINGRETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONING
RETROVIRUS MEDIATED GENE TRANSFER AND EXPRESSION CLONING
 

More from Alichy Sowmya

Plant tissue culture
Plant tissue culturePlant tissue culture
Plant tissue culture
Alichy Sowmya
 
Protein data bank
Protein data bankProtein data bank
Protein data bank
Alichy Sowmya
 
Probability distribution in R
Probability distribution in RProbability distribution in R
Probability distribution in R
Alichy Sowmya
 
Regression analysis in R
Regression analysis in RRegression analysis in R
Regression analysis in R
Alichy Sowmya
 
Chemistry development kit
Chemistry development kitChemistry development kit
Chemistry development kit
Alichy Sowmya
 
Validation of homology modeling
Validation of homology modelingValidation of homology modeling
Validation of homology modeling
Alichy Sowmya
 
Big data in metabolism
Big data in metabolismBig data in metabolism
Big data in metabolism
Alichy Sowmya
 
PHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY EVALUATION OF DECALEPIS HAMILTONII
PHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY  EVALUATION OF DECALEPIS HAMILTONIIPHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY  EVALUATION OF DECALEPIS HAMILTONII
PHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY EVALUATION OF DECALEPIS HAMILTONII
Alichy Sowmya
 
SciFinder and its utility in Drug discovery
SciFinder and its utility in Drug discoverySciFinder and its utility in Drug discovery
SciFinder and its utility in Drug discovery
Alichy Sowmya
 
Prescription filling record
Prescription filling recordPrescription filling record
Prescription filling record
Alichy Sowmya
 
Information science
Information scienceInformation science
Information science
Alichy Sowmya
 
Limitations of in silico drug discovery methods
Limitations of in silico drug discovery methodsLimitations of in silico drug discovery methods
Limitations of in silico drug discovery methods
Alichy Sowmya
 

More from Alichy Sowmya (12)

Plant tissue culture
Plant tissue culturePlant tissue culture
Plant tissue culture
 
Protein data bank
Protein data bankProtein data bank
Protein data bank
 
Probability distribution in R
Probability distribution in RProbability distribution in R
Probability distribution in R
 
Regression analysis in R
Regression analysis in RRegression analysis in R
Regression analysis in R
 
Chemistry development kit
Chemistry development kitChemistry development kit
Chemistry development kit
 
Validation of homology modeling
Validation of homology modelingValidation of homology modeling
Validation of homology modeling
 
Big data in metabolism
Big data in metabolismBig data in metabolism
Big data in metabolism
 
PHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY EVALUATION OF DECALEPIS HAMILTONII
PHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY  EVALUATION OF DECALEPIS HAMILTONIIPHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY  EVALUATION OF DECALEPIS HAMILTONII
PHARMACOGNOSTICAL AND BIOLOGICAL ACTIVITY EVALUATION OF DECALEPIS HAMILTONII
 
SciFinder and its utility in Drug discovery
SciFinder and its utility in Drug discoverySciFinder and its utility in Drug discovery
SciFinder and its utility in Drug discovery
 
Prescription filling record
Prescription filling recordPrescription filling record
Prescription filling record
 
Information science
Information scienceInformation science
Information science
 
Limitations of in silico drug discovery methods
Limitations of in silico drug discovery methodsLimitations of in silico drug discovery methods
Limitations of in silico drug discovery methods
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 

Crimean Congo Hemorrhagic fever

  • 1. A Computational Approach to Explore Crimean Congo Hemorrhagic Fever PRESENTED BY: ALICHY SOWMYA REG. NO. 18PIM2855 M.S.(PHARM.) 1ST SEM. DEPARTMENT OF PHARMACOINFORMATICS NIPER, S.A.S NAGAR
  • 3. • Crimean Congo Hemorrhagic Fever is a disease caused by an Arbovirus, CCHFV with a mortality rate of 6% to 50% • The first description of hemorrhagic fever similar to that of CCHF was done in 12th century • Officially it was first described, in 1940s in the Crimean peninsula, and later in 1956 in Congo • It is geographically widespread, ranging from the Middle East and Asia to South Africa and Eastern Europe • CCHFV is biosafety level-4 virus making it difficult to study Introduction: 2 Mendoza, E., et al.,, Zoonoses Public Health. 2018, 65, 465-480.
  • 4. Epidemiology: • The disease is endemic in many countries in Africa, Europe and Asia, and outbreaks have been recorded in Kosovo, Albania, Islamic Republic of Iran, Pakistan, India, and South Africa among other countries • In between 2002 – 2008 , 2508 cases of CCHF with 133 deaths have been reported in Turkey alone • In September, 2010 an outbreak was reported in Pakistan with a case-fatality rate above 10% • In SEAR, the first laboratory confirmed case was reported on 19 January, 2011 in Gujarat state of India 3 http://www.searo.who.int/entity/emerging_diseases/links/CCHF_Fact_Sheet_SEARO.pdf (21 nov 10:30am).
  • 5. Scenario in India: • In India first case of CCHF was reported in Jan 2011, in Gujarat, then there was a nosocomial outbreak talking 3 lives • Again in 2013, there was a outbreak in Karyana village, Amreli district, Gujarat State • CCHF-positive and fatal human cases were reported from Patan, Rajkot, Surendranagar, and Ahmadabad districts in Gujarat State • In may 2018, CCHF was reported in Sirohi district, Rajasthan state Mishra et al., Lancet. 2011, 378, 372. 4
  • 6. Causative agent: • CCHFV is a second most widely distributed arbovirus after dengue virus • Classification: • Virion structure and molecular biology: Flick, R.et al., Curr. Mol. Med. 2005, 5, 753-760. Contd… 5
  • 7. • Transmission of virus: Small Mammals and birds Nymph Larva Drop off and Molt Oviposition and Hatching Adult Humans (Nosocomial transmissions) Contd… 6 Aslam, S., et al.,, Biomed Rep. 2016, 4, 15-20.
  • 8. Pathophysiology: CCHFV Tick bite Entry from epithelium Basolateral compartment Release in the endothelial cells Basolateral compartment Spread into the blood stream Dissemination into liver and other tissues Release of cytokines Upregulation of the adhesion molecules Damage of the immune system Necrosis with little or no inflammation Activation of Endothelial cells and damage of the endothelium Uncontrolled viral replication Initiation of the inflammatory reactions Intrinsic coagulation cascade activated Vascular permeability and vasodilation are increased Disseminated intravascular coagulation Hypotension, multiple organ failure and shockHemorrhages Liver dysfunction Hemophagocytosis CCHFV Infected dendritic cells and Macrophages Spread to local lymph nodes and spleen 7 Arasli, M., Curr Trop Med Rep. 2016, 3, 14-19.
  • 9. Clinical Features: • The CCHFV infection can be characterised by four characteristic stages viz., incubation, prehemorrhagic, hemorrhagic, and convalescence Melena Epistaxis Ecchymosis Petechiae Ergönül, Ö.et al., Emerg. Infect. Dis. 2018, 24, 1642. 8
  • 10. Treatment: • CCHF is a severe disease in humans, with a high mortality rate, but unfortunately there is no specific treatment available till date • General supportive therapy is the mainstay of patient management in CCHF. Intensive monitoring to guide volume and blood component replacement is required • The antiviral drug ribavirin has been used in treatment of established CCHF infection with apparent benefit, but effectiveness is yet to be proven 9 http://www.searo.who.int/entity/emerging_diseases/links/CCHF_Fact_Sheet_SEARO.pdf (21 nov 10:30am).
  • 11. Prevention and control: • As it is a tick borne virus acaricides (chemicals intended to kill ticks) can be an option • Persons living in endemic areas should use personal protective measures • Patients with suspected or confirmed CCHF should be isolated and cared for using barrier nursing techniques. Proper measures are to be taken to prevent nosocomial transmission • Healthcare workers are at risk of acquiring infection and therefore they should take proper precautions • Community education initiatives should be instituted in the event of an observed outbreak 10 http://www.searo.who.int/entity/emerging_diseases/links/CCHF_Fact_Sheet_SEARO.pdf (21 nov 10:30am).
  • 12. Literature review: 11 • Javadmanesh Ali et al., have conducted in silico evaluation of the antiviral effects of the lactoferrin against the envelopment protein (Gn and Gc) of the CCHFV • Sitansu Kumar Verma et al., have conducting docking studies to explore the binding sites for the antiviral compounds in RdRp of CCHFV • Fatih Kocabas et al., used computational approaches for identification of inhibition site in OTU Domain of CCHFV
  • 14. • Materials and methods:  Preparation of the target structure for docking  Preparation of the docked entity  Predicting CCHFV N binding site  High – throughput docking studies  Classical Molecular dynamic simulation  Ensemble – based docking simulations  Virtual screening procedure • Results:  CCHFV N druggable pocket  Finding putative inhibitors  Molecular dynamic studies Contd… Contd… 13
  • 15. Contd… Contd… Preparation of the target structure for docking: •The X Ray crystallographic structure of CCHFV nucleoprotein was deposited in the PDB along with sulfate ion as a ligand with ID 4AQG with a resolution of 2.8 Å •They have downloaded the structure and upon studying they have found that the amino acid sequence was missing of 12 amino acid sequences which were later added using SWISS - MODEL •The sequences from Leu181 to Ser194 were added 14
  • 17. Contd… Contd… Predicting CCHFV N binding site: •In this study for determining the binding pocket, they have used DoGsiteScorer server •Then they have used Poisson Boltzmann solver (APBS) method of PyMol software to determine the positive charges High – throughput docking studies: •After the binding pockets have been recognized they have predicted the binding poses and affinities of the compounds over the predicted binding site of CCHFV Nucleoprotein •For this determination AutoDock Vina 1.1.2 with 40 – 34 – 40 search space was used 16
  • 18. Classical Molecular dynamic simulation: •Initially, they have used PRODRG server to generate the topology files of the ligand •The corrections regarding their protonation states was made using the PROPKA server and finally GROMAC was used •The molecular dynamics simulation was done for 10 ns Ensemble – based docking simulations: •In this study, the ensemble was made using molecular dynamic simulation •The simulation was performed for 10 nanoseconds (ns) and for every 2.5 ns a snapshot was taken Contd… Contd… 17
  • 20. Contd… Contd… Results: CCHFV N druggable pocket: •Using DoGsiteScorer server they have recognised three pockets which are allegedly be the potential binding pocket. The three pockets were as follows: • Pocket1 (between head and tail domains) • Pocket 2 (in the head domain) • Pocket 3 (in the head domain) •It was found that pocket 1 and pocket 3 consists of both positive and negative charges, and the pocket 2 contains more positive charge 19
  • 21. Contd… Contd…Sharifi. A et al., Comput. Biol. Chem. 2017, 70, 1-6. Three predicted pockets over CCHFV N protein are coloured by yellow, cyan and magenta 20
  • 22. Contd… Contd… Finding putative inhibitors: •1584 FDA approved drugs were docked with the cut-off value of -8 kcal/mol and 25 hits were retained •After the screening procedure only Doxycycline and Minocycline have been selected •The docking conformation of doxycycline shows two hydrogen bonds with Leu387 and one with Lys411 besides hydrophobic interactions with Ala302, Ile373, and Ile448 •Minocycline predicted pose comprises only one hydrogen bond with Ser386 in addition to hydrophobic contact with Ala302, Thr381, and Ile448 residues •It was hypothesized that doxycycline inhibits the protein more desirable than minocycline, as it is in accordance with their obtained binding energies 21
  • 23. Contd… Contd… A. Binding orientation of doxycycline B. Binding orientation of minocycline C. Alignment of both drugs 22 Sharifi. A et al., Comput. Biol. Chem. 2017, 70, 1-6.
  • 24. Contd… Molecular dynamic studies: •The Root Mean Square Deviation (RMSD) of the protein backbone reveals that the suggested ligand – protein complex reach stability at same time (A) MD graphs of doxycycline and minocycline (B) The RMSD plot of protein ligand complex 23 Sharifi. A et al., Comput. Biol. Chem. 2017, 70, 1-6.
  • 25. Conclusion: • CCHFV is one of the most dangerous classes of the virus and it was suggested CCHFV Nucleoprotein could be a potential pharmaceutical target for inhibiting CCHFV • FDA approved drugs were docked 25 dugs were filtered, virtual screening of these 25 drugs were conducted and two drugs, namely Doxycycline and Minocycline were selected • Molecular dynamic simulation of CCHFV N protein was done for 10ns with a snapshot taken for every 2.5ns i.e., 4 snapshots or 4 conformations of the protein were identified and the two drugs Doxycycline and Minocycline were docked over those 4 conformers • It was found that both bind to all conformers with equal affinity and RMSD revealed that the protein-ligand complex is more stable than that of protein without ligand 24